RBF Capital’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

RBF Capital’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-563	Closed	-$11K	–	542
2022 Q4	$11K	Sell	563 -20	-3%	-$377	﹤0.01%	527
2022 Q3	$16K	Hold	583	–	–	﹤0.01%	529
2022 Q2	$15K	Buy	+583	New	+$25.9K	﹤0.01%	525

Other funds holding VINC

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SRC

Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

RBF Capital's VINC Position: Q1 2023 in Review

RBF Capital sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q1 2023, closing a stake of 563 shares — an estimated $11K sold.

RBF Capital first reported a position in VINC in Q2 2022 and held it in 3 quarters. The position peaked at $16K in Q3 2022. 36 funds tracked by Wall St. Rank hold VINC as of Q1 2023.

RBF Capital reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
RBF Capital sold 563 Vincerx Pharma, Inc. Common Stock shares in Q1 2023, an estimated $11K.
RBF Capital first reported a position in Vincerx Pharma, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
RBF Capital's Vincerx Pharma, Inc. Common Stock position peaked at $16K in Q3 2022.
36 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q1 2023.

Based on RBF Capital's 13F filing for Q1 2023, filed 16 May 2023.